These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11943729)

  • 61. Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique.
    Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R
    Virchows Arch; 2004 Dec; 445(6):631-6. PubMed ID: 15517366
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
    Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Skp2/p27 expression profile is correlated with Epstein-Barr virus status in extranodal nasal-type natural killer cell lymphoma.
    Xiang-Lan M; Zu-Lan S; Dan H; Bi-Hong S; Ya-Qin P; Han-Liang L
    Transl Res; 2008 Jun; 151(6):303-8. PubMed ID: 18514141
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
    Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
    Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
    [TBL] [Abstract][Full Text] [Related]  

  • 65. S-phase kinase-associated protein 2 knockdown blocks colorectal cancer growth via regulation of both p27 and p16 expression.
    Xu SY; Wang F; Wei G; Wang B; Yang JY; Huang YZ; Zhang L; Zheng F; Guo LY; Wang JN; Tang JM
    Cancer Gene Ther; 2013 Dec; 20(12):690-4. PubMed ID: 24336114
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deregulated degradation of the cdk inhibitor p27 and malignant transformation.
    Bloom J; Pagano M
    Semin Cancer Biol; 2003 Feb; 13(1):41-7. PubMed ID: 12507555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Merkel cell carcinomas: expression of S-phase kinase-associated protein 2 (Skp2), p27, and proliferation markers.
    Erickson LA; Papotti M; Volante M; Jin L; Lewis JE; Lloyd RV
    Endocr Pathol; 2003; 14(3):221-29. PubMed ID: 14586067
    [TBL] [Abstract][Full Text] [Related]  

  • 68. S-phase kinase protein 2 is an attractive therapeutic target in a subset of diffuse large B-cell lymphoma.
    Uddin S; Hussain A; Ahmed M; Belgaumi A; Al-Dayel F; Ajarim D; Bavi P; Al-Kuraya KS
    J Pathol; 2008 Dec; 216(4):483-94. PubMed ID: 18850583
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The SKP2-p27 axis defines susceptibility to cell death upon CHK1 inhibition.
    Lohmüller M; Roeck BF; Szabo TG; Schapfl MA; Pegka F; Herzog S; Villunger A; Schuler F
    Mol Oncol; 2022 Aug; 16(15):2771-2787. PubMed ID: 35673965
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Expression of Spy1 protein in human non-Hodgkin's lymphomas is correlated with phosphorylation of p27 Kip1 on Thr187 and cell proliferation.
    Hang Q; Fei M; Hou S; Ni Q; Lu C; Zhang G; Gong P; Guan C; Huang X; He S
    Med Oncol; 2012 Dec; 29(5):3504-14. PubMed ID: 22492278
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CDK1 and cyclin A expression is linked to cell proliferation and associated with prognosis in non-Hodgkin's lymphomas.
    Wolowiec D; Berger F; Ffrench P; Bryon PA; Ffrench M
    Leuk Lymphoma; 1999 Sep; 35(1-2):147-57. PubMed ID: 10512172
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients.
    Drobnjak M; Melamed J; Taneja S; Melzer K; Wieczorek R; Levinson B; Zeleniuch-Jacquotte A; Polsky D; Ferrara J; Perez-Soler R; Cordon-Cardo C; Pagano M; Osman I
    Clin Cancer Res; 2003 Jul; 9(7):2613-9. PubMed ID: 12855638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma.
    Ferreri AJ; Ponzoni M; Pruneri G; Freschi M; Rossi R; Dell'Oro S; Baldini L; Buffa R; Carboni N; Villa E; Viale G
    Int J Cancer; 2001 Nov; 94(4):599-604. PubMed ID: 11745451
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prognostic implications of p27 and cyclin E protein contents in malignant lymphomas.
    Erlanson M; Landberg G
    Leuk Lymphoma; 2001 Feb; 40(5-6):461-70. PubMed ID: 11426519
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of the F-box protein Skp2 in cell proliferation in the developing auditory system in mice.
    Dong Y; Nakagawa T; Endo T; Kim TS; Iguchi F; Yamamoto N; Naito Y; Ito J
    Neuroreport; 2003 Apr; 14(5):759-61. PubMed ID: 12692478
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associations and prognostic significance of p27
    Ma Y; Yan M; Huang H; Zhang L; Wang Q; Zhao Y; Zhao J
    Mol Clin Oncol; 2016 Oct; 5(4):357-364. PubMed ID: 27703676
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma.
    Morosétti R; Kawamata N; Gombart AF; Miller CW; Hatta Y; Hirama T; Said JW; Tomonaga M; Koeffler HP
    Blood; 1995 Sep; 86(5):1924-30. PubMed ID: 7655021
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 in feline lymphoma.
    Madewell B; Griffey S; Walls J; Gandour-Edwards R
    Vet Pathol; 2001 Nov; 38(6):698-702. PubMed ID: 11732804
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
    Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
    Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of p34(cdc2) and cyclins A and B compared to other proliferative features of non-Hodgkin's lymphomas: a multivariate cluster analysis.
    Leoncini L; Cossu A; Megha T; Bellan C; Lazzi S; Luzi P; Tosi P; Barbini P; Cevenini G; Pileri S; Giordano A; Kraft R; Laissue JA; Cottier H
    Int J Cancer; 1999 Oct; 83(2):203-9. PubMed ID: 10471528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.